Wave Life Sciences, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINEARSWave Life Sciences, Inc.WVE4d

   Wave Life Sciences files ARS

   • Form ARS filed on 2026-10-14
   • Submitted by Wave Life Sciences, Inc.
   • Contains financial and operational data
2. ROUTINEDEF 14AWave Life Sciences, Inc.WVE4d

   Wave Life Sciences 2026 Annual Meeting

   • Annual meeting on Nov 12, 2026 at 733 Concord Ave, Cambridge, MA
   • 9 directors to be elected
   • KPMG LLP to be ratified as independent auditor
3. ROUTINE4Wave Life Sciences, Inc.WVEOct 8

   8 insider filings

   Heidi L Wagner, insider filing for WVE

   Show all 8

   • 4Insider filing for WVEOct 8
   • 4Insider filing for WVEOct 8
   • 4Insider filing for WVEOct 8
   • 4Insider filing for WVEOct 8
   • 4Insider filing for WVEOct 8
   • 4Insider filing for WVEOct 8
   • 4Insider filing for WVEOct 8
   • 4Insider filing for WVEOct 8

   Heidi L Wagner, reporting

4. ROUTINEEFFECTWave Life Sciences, Inc.WVEAug 17

   Registration declared effective

5. ROUTINE4Wave Life Sciences, Inc.WVEAug 13

   4 insider filings

   Heidi L Wagner, insider filing for WVE

   Show all 4

   • 4Insider filing for WVEAug 13
   • 4Insider filing for WVEAug 13
   • 4Insider filing for WVEAug 13
   • 4Insider filing for WVEAug 13

   Heidi L Wagner, reporting

6. ROUTINE144Wave Life Sciences, Inc.WVEAug 12

   Adrian Rawcliffe, planned sale of WVE shares

   Adrian Rawcliffe, reporting

7. NOTABLESCHEDULE 13D/AWave Life Sciences, Inc.WVEAug 11

   Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

   RA CAPITAL MANAGEMENT, L.P., filed by

8. ROUTINE144Wave Life Sciences, Inc.WVEAug 11

   Heidi L Wagner, planned sale of WVE shares

   Heidi L Wagner, reporting

9. ROUTINE8-K12BWave Life Sciences, Inc.WVEAug 7

   8-K12B filing

10. NOTABLE10-QWave Life Sciences Ltd.WVEJul 30

    Quarterly report

11. ROUTINE8-KWave Life Sciences Ltd.WVEJul 30

    Current report

12. ROUTINE8-KWave Life Sciences Ltd.WVEJun 26

    Current report

13. ROUTINE8-KWave Life Sciences Ltd.WVEMay 18

    Current report

14. ROUTINESCHEDULE 13G/AWave Life Sciences Ltd.WVEMay 13

    Ownership stake disclosure by Adage Capital Management, L.P. (amended)

    Adage Capital Management, L.P., filed by

15. ROUTINEDEF 14AWave Life Sciences Ltd.WVEMay 7

    Proxy statement

16. ROUTINESCHEDULE 13G/AWave Life Sciences Ltd.WVEMay 6

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

17. ROUTINEPRER14AWave Life Sciences Ltd.WVEMay 1

    PRER14A filing

18. ROUTINE10-K/AWave Life Sciences Ltd.WVEApr 30

    Annual report (amended)

19. NOTABLE10-QWave Life Sciences Ltd.WVEApr 28

    Quarterly report

20. ROUTINE8-KWave Life Sciences Ltd.WVEApr 28

    Current report

21. ROUTINEDEFA14AWave Life Sciences Ltd.WVEApr 21

    Additional proxy materials

22. ROUTINE8-KWave Life Sciences Ltd.WVEApr 21

    Current report

23. ROUTINE3Wave Life Sciences Ltd.WVEApr 17

    2 insider filings

    Erik Ingelsson, new insider at WVE

    Show all 2

    • 3New insider at WVEApr 17
    • 3New insider at WVEApr 17

    Erik Ingelsson, reporting

24. NOTABLESCHEDULE 13D/AWave Life Sciences Ltd.WVEApr 17

    Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

    RA CAPITAL MANAGEMENT, L.P., filed by

25. ROUTINEPRE 14AWave Life Sciences Ltd.WVEApr 15

    Preliminary proxy statement

26. ROUTINEDEFA14AWave Life Sciences Ltd.WVEApr 15

    Additional proxy materials

27. ROUTINE8-KWave Life Sciences Ltd.WVEApr 15

    Current report

28. NOTABLESCHEDULE 13D/AWave Life Sciences Ltd.WVEMar 30

    Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

    RA CAPITAL MANAGEMENT, L.P., filed by

29. ROUTINE4Wave Life Sciences Ltd.WVEMar 30

    RA Capital Healthcare Fund LP, insider filing for WVE

    RA Capital Healthcare Fund LP, reporting · RA CAPITAL MANAGEMENT, L.P., reporting · +2 more

30. ROUTINE4Wave Life Sciences Ltd.WVEMar 26

    Ken Takanashi, insider filing for WVE

    Ken Takanashi, reporting

31. ROUTINE8-KWave Life Sciences Ltd.WVEMar 26

    Current report

32. ROUTINE4Wave Life Sciences Ltd.WVEFeb 27

    Chris Francis, insider filing for WVE

    Chris Francis, reporting

33. NOTABLE10-KWave Life Sciences Ltd.WVEFeb 26

    Annual report

34. ROUTINE8-KWave Life Sciences Ltd.WVEFeb 26

    Current report

35. ROUTINESCHEDULE 13G/AWave Life Sciences Ltd.WVEFeb 12

    Ownership stake disclosure by Adage Capital Management, L.P. (amended)

    Adage Capital Management, L.P., filed by

36. ROUTINE4Wave Life Sciences Ltd.WVEFeb 11

    4 insider filings

    Kyle Moran, insider filing for WVE

    Show all 4

    • 4Insider filing for WVEFeb 11
    • 4Insider filing for WVEFeb 11
    • 4Insider filing for WVEFeb 11
    • 4Insider filing for WVEFeb 11

    Kyle Moran, reporting

Older filings on EDGAR